The European Medicines Agency’s management board “regrets” that the agency was not permitted to use funds from its original budget for 2016 for a Brexit contingency reserve.
The currently London-based EMA saw its initial 2016 budget cut by €16.3m from €324.7m to €308.4m as a result of a considerable weakening of sterling in the wake of the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?